Meter, IQ-SurgiView and IQ-Flow demonstrated live for the first time; surgeons single out robotic visualization, console-free ECP and a compact all-in-one diagnostic suited to office-based surgery ...
Full results from the positive Phase III CROSSING trial showed that AstraZeneca and Amgen's Tezspire (tezepelumab) demonstrated statistically ...
AstraZeneca and Amgen reported Phase III CROSSING data showing that Tezspire (tezepelumab) improved histologic remission and swallowing symptoms versus placebo in adolescents and ...
Full results from the positive Phase III CROSSING trial showed that AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab) demonstrated statistically significant and clinically meaningful improvements in the ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced full results from the positive Phase 3 CROSSING trial that showed TEZSPIRE ® (tezepelumab-ekko) demonstrated statistically significant and ...
Two of five patients had endoscopic response; two had endoscopic remission. Palisade is enrolling Phase 2b UC and initiating ...
Good morning!Until a while ago, were there any of you who were told, “You have chronic gastritis”?Chronic gastritis is, ...
Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ...
A retrospective cohort study finds that routine endoscopic and CT response assessments show only limited ability to predict ...
Detecting blood in the urine can be an important warning sign that leads to early detection for urinary tract cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results